Business
Cannabics Pharmaceuticals Inc. Provides Shareholders Update Regarding Increased Volume in its Shares
Cannabics Pharmaceuticals Inc. Provides Shareholders Update Regarding Increased Volume in its Shares.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Inc. Provides Shareholders Update Regarding Increased Volume in its Shares\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCannabics Pharmaceuticals Inc. Provides Shareholders Update Regarding Increased Volume in its Shares\nPR Newswire\nBETHESDA, Maryland, Feb. 23, 2017\n\n\n\nBETHESDA, Maryland, Feb. 23, 2017 /PRNewswire/ -- The management of Cannabics Pharmaceuticals Inc. (CNBX) wishes to inform its shareholders and public at large that is acutely aware of the significant increase in its share volume this past month and was contacted by OTC Markets on February 21st regarding this matter. \n\n\n \n \n\n \nItamar Borochov, CEO of Cannabics Pharmaceuticals, says \"We are very aware of the increased interest in our science and its apparent results in the marketplace.\" I wish to reiterate that there is neither any undisclosed material information available nor any paid promotional activity or Investor Relations for the Company at all. The sole source of the Company's public information has been press releases which we, the Company, authorize and release ourselves and may be found under \"News\" on OTC Markets site or on our Website (www.Cannabics.com). \n\nThe company believes that its planned commercialization of its Liquid Biopsy Diagnostic tests as announced in our Press Release of February 6th, 2017, contributed to the recent increased activity. As stated in that release, the Company is on track to begin testing patients beginning in March. The Company believes the rapidly increasing awareness and interest in companies operating in the field of cannabinoid based biotechnology has simply created heightened demand. \n\nIn closing, the public is to be reminded that investments in any type of securities are highly speculative, and that the only announcements or information about Cannabics Pharmaceuticals which are condoned by the Company or to be relied upon must come from the Company itself, and bear our name as its Source. \n\nThe Company avers that it shall keep the public timely and accurately informed of significant events ...